Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis

Thrombosis Research

Volumn 112, Issue 1-2, 2003, Pages 65-71

  Jones, Chris I ^a   Goodall, Alison H ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Contrast media; Fibrinolysis; Platelets; Thrombi

Indexed keywords

ANTIBODY; FIBRINOGEN; FLUORESCEIN ISOTHIOCYANATE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOXAGLIC ACID; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; PROPIDIUM IODIDE;

BLOOD CLOT LYSIS; BLOOD CLOTTING; CONFERENCE PAPER; CONTROLLED STUDY; DEGRANULATION; ERYTHROCYTE; FIBRINOLYSIS; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBUS;

EID: 0842346101     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.031     Document Type: Conference Paper

References (32)

1. Corot C., Perrin J.M., Bellville J., Amiel M., Eloy R. Effect of iodinated contrast media on blood clotting. Invest. Radiol. 24:1989;390-393.
2. Kopko P.M., Smith D.C., Bull B.S. Thrombin generation in non-clottable mixtures of blood and non-ionic contrast agents. Radiology. 174:1990;459-461.
3. Corot C., Chronos N., Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagul. Fibrinolysis. 7:1996;602-608.
4. Al Dieri R., Beguin S., Hemker C. Anticoagulant and antiplatelet effect of an ionic iodinated contrast medium, but not of a non-ionic one. Am. J. Cardiol. 86(Suppl. 8A):2000;100i.
5. Idee J.M., Corot C. Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects. Fundam. Clin. Pharmacol. 13(6):1999;613-623.
6. Jung F., Spitzer S.G., Pindur G. Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterization. Pathophysiol. Haemost. Thromb. 32:2002;121-126.
7. Levi M., Biemond B., Sturk A., ten Cate J.W. Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis model. Thromb. Haemost. 66:1991;218-221.
8. Grines C.L., Mickelson J.K., Diaz C., DeMaria A.N. Acute thrombosis in a canine model of arterial injury: effect of ionic versus non-ionic contrast media. J. Invas.Cardiol. 3:1991;18B-23B. [suppl.].
9. Moncada R., Breddin K., Iqbal O., Fareed J. Comparative procoagulant actions of ionic and non-ionic contrast media as studied in a rat model of laser induced thrombosis. Thromb. Haemost. 69:1993;1027.
10. Corot C., Stucker O., Duverger J.P., Pons C., Vicaut E. Effect of iodinated contrast agents on the formation of platelet thrombi in the micro arterioles of rats. Invest. Radiol. 29:1994;S203-S205.
11. Labarthe B., Idée J.M., Burnett R., Corot C. In vivo comparative antithrombotic effects of Ioxaglate and Iohexol and interaction with the platelet antiaggregant Clopidogrel. Invest. Radiol. 38:2003;34-43.
12. Robertson H. Blood clot formation in angiographic syringes containing non-ionic contrast media. Radiology. 163:1987;621-622.
13. Zhu Y., Tomasiak R., Fay W.P. Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis? Thromb. Res. 105:2002;413-418.
14. Corot C., Cormillas A., Belleville J., Eloy R. Scanning electron microscopic analysis of catheters during routine angiographic procedures. Role of the contrast agent. Invest. Radiol. 26(Suppl. 1):1991;S96-S100.
15. Markou C.P., Chronos N.A.F., Hanson S.R. Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb. Haemost. 85:2001;488-493.
16. Grabowski E.F., Rodriguez M., McDonnell S.L. Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis. Catheter. Cardiovasc. Diagn. 28:1993;65-71.
17. Dalby M.C.D., Davidson S.J., Burman J.F., Clague J., Sigwart U., Davies S.W. Systemic platelet effects of contrast media: implications for cardiologic research and clinical practice. Am. Heart J. 143(1):2002;E1.
18. Eloy R., Corot C., Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin. Mater. 7:1991;89-197.
19. Chronos N.A.F., Goodall A.H., Wilson D.J., Sigwart U., Buller N.P. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation. 88:1993;2035-2044.
20. Grabowski E.F., Jang I.V., Gold H., Head C., Benoit S.E., Michelson A.D. Variability of platelet degranulation by different contrast media. Acta Radiol. 3:1995;S485-S487.
21. Heptinstall S., White A., Edwards N., Pascoe J., Sanderson H.M., Fox S.C.et al. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice. Br. J. Haematol. 103:1998;1023-1030.
22. Li X., Gabriel D.A. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad. Radiol. 4:1997;108-114.
23. Al Dieri R., Beguin S., Hemker H.C. The ionic contrast medium Ioxaglate interferes with thrombin-mediated activation of factor V, factor VIII and platelets. J. Thromb. Haemost. 1:2003;269-274.
24. Gabriel D.A., Jones M.R., Reese N.S., Boothroyd E., Bashore T.M. Platelet and fibrin modification by radiographic contrast media. Circ. Res. 68:1991;881-887.
25. Granger C.B., Gabriel D.A., Reese N.S., Boothroyd E., Harding M.B., Harrison J.K.et al. Fibrin modification by ionic and non-ionic contrast media during cardiac catheterisation. Am. J. Cardiol. 69:1992;821-823.
26. Melton L.D., Dehmer G.J., Gabriel D.A. Alterations in fibrin detected in coronary sinus blood after heparin and coronary angiography with a non-ionic contrast agent (Iohexol). Am. J. Cardiol. 82:1998;295-298.
27. Farrehi P.M., Zhu Y., Fay W.P. An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents. J. Thromb. Thrombolysis. 12(3):2001;273-281.
28. Carr M.E., Carr S.L., Merten S.R. Effects of ionic and non-ionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots. Haemostasis. 25:1995;172-181.
29. Dehmer G.J., Grealfi N., Daly D., Oberhardt B., Tate D.A. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. JACC. 25:1995;1069-1075.
30. Chandler A.B. In vitro thrombotic coagulation of blood. Lab. Invest. 7:1958;110-114.
31. Robbie L.A., Young S.P., Bennett B., Booth N.A. Thrombi formed in the Chandler loop mimic human arterial thrombi in structure and PAI-1 content and distribution. Thromb. Haemost. 77:1997;510-515.
32. Sutton A.G., Ashton V.J., Cambell P.G., Price D.J., Hall J.A., de Belder M.A. A randomized prospective trial of Ioxaglate 320 (Hexabrix) vs. Iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention. Catheter. Cardiovasc. Interv. 57(3):2002;346-352.